1 packet 50gm

$43.50

Carbosorb X (does not contain sorbitol), carbosorb XS (contains sorbitol)

  • Single dose activated charcoal is indicated where it is likely that toxin remains in the gastrointestinal tract (i.e. within one hour of ingestion for most agents) and where the potential benefits outweigh the potential risk

  • Multiple dose activated charcoal may be indicated for agents that undergo enterohepatic recirculation and are adsorbed by activated charcoal. Such agents are carbamazepine, dapsone, phenobarbitone, quinine & theophylline

PO / NG:
Carbosorb XS contains 50gm activated charcoal and 99.8g of sorbitol in 250ml
Carbosorb X contains 50gm activated charcoal in 250ml
Give to the patient in a cup for self administration
Note: there are no data to support the use of activated charcoal in sorbitol or other cathartic over activated charcoal in water (generally, therefore, carbosorb X is preferred)


ADULT DOSE
PO:
Single dose: 50gm
Multiple dose: give an initial dose of activated charcoal 50gm and follow with repeated doses of 25gm every 2 hours (check for bowel sounds prior to administration of each dose and cease administration if bowel sounds are absent). Reconsider the indication every 6 hours.

PAEDIATRIC DOSE
PO:
Single dose: children greater than one month 1gm/kg (max 50g)
Multiple dose: give an initial dose of activated charcoal 1gm/kg and follow with repeated doses of 0.5gm/kg every 2 hours (check for bowel sounds prior to administration of each dose and cease administration if bowel sounds are absent). Reconsider the indication every 6 hours.

DOSAGE IN RENAL FAILURE AND RENAL REPLACEMENT THERAPY
Dose as in normal renal function

Carbosorb X (does not contain sorbitol), carbosorb XS (contains sorbitol). Charcoal is an adsorbent. Sorbitol is a cathartic.

Activated charcoal is produced by super-heating of distilled wood pulp. The resulting fine porous particles are suspended in water (or sorbitol). The particles have a very large surface area and readily absorb most ingested toxins in the gastrointestinal tract.

CONTRAINDICATIONS:

  • Decreased level of consciousness without airway protection

  • Bowel obstruction

  • Intoxication due to a substance that is not adsorbed by charcoal (i.e hydrocarbons, alcohols, metals and corrosives)

  • Non-toxic ingestion or sub-toxic dose

Note: if mental status precludes self-administration, activated charcoal should be withheld until the patient is intubated if and when this becomes clinically necessary. Only in very rare circumstances does the risk assessment justify intubation specifically to administer charcoal.

WARNINGS
Do not use activated charcoal if risk assessment suggests the potential for imminent onset of seizures or the potential for a rapid decrease in conscious state.

PRECAUTIONS
General
Activated charcoal may lead to impaired absorption of medications administered via the oral route.

Laboratory Tests:
No tests in addition to routine ICU tests are required

Drug/Laboratory Test Interactions:
None known

Activated charcoal may lead to impaired absorption of medications administered via the oral route.

Respiratory System:
Pulmonary aspiration of charcoal (esp if decreased conscious state or seizures)
Digestive System:
Vomiting, constipation, charcoal bezoar formation, perforation, obstruction

[an error occurred while processing this directive]